4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001628280-23-039321
Chief Medical Officer returned 2,098 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Podnos Yale Chief Medical Officer | 2023-11-14 | Returned to the company | −238 | $2.39 | $568 | 90,228 | D |
| Podnos Yale Chief Medical Officer | 2023-11-14 | Returned to the company | −1,860 | $2.39 | $4,436 | 88,368 | D |
Loading xslF345X05/wk-form4_1700170789.xml…